FdaApplication
BLA 761140
Identifiers
- fda_app_no: BLA761140
Properties
| Property | Value |
|---|---|
| applicant_name | Amgen Inc. |
| application_type | BLA |
| approval_date | 2020-12-17 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RIABNI | RITUXIMAB-ARRX | 100MG/10ML (10MG/ML) | Injection |
| RIABNI | — | 500MG/50ML (10MG/ML) | Injection |
2 products